Publication Date:
2012-06-16
Description:
〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Cannon, Christopher P -- Cannon, Paul J -- New York, N.Y. -- Science. 2012 Jun 15;336(6087):1386-7. doi: 10.1126/science.1224398.〈br /〉〈span class="detail_caption"〉Author address: 〈/span〉Thrombolysis in Myocardial Infarction Study Group, Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA. cpcannon@partners.org〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/22700906" target="_blank"〉PubMed〈/a〉
Keywords:
Animals
;
Cardiovascular Diseases/chemically induced
;
Cyclooxygenase 2/genetics/*metabolism
;
Cyclooxygenase 2 Inhibitors/*adverse effects/pharmacology
;
Endothelial Cells/*enzymology
;
Epoprostenol/metabolism
;
Genetic Engineering
;
Humans
;
Hypertension/*chemically induced
;
Mice
;
Muscle, Smooth, Vascular/*enzymology
;
Risk Factors
;
Thrombosis/*chemically induced
Print ISSN:
0036-8075
Electronic ISSN:
1095-9203
Topics:
Biology
,
Chemistry and Pharmacology
,
Computer Science
,
Medicine
,
Natural Sciences in General
,
Physics
